Research and Development

Showing 15 posts of 9578 posts found.

Merck rebrands as ‘science and technology’ company

October 14, 2015 Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Merck Serono, rebrand, restructure

Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …
Teva image

Teva joins Watson Health in R&D link-up

October 14, 2015 Research and Development Big Data, R&D, Teva, Watson Health, ibm

Teva has partnered with the IBM Watson Health Cloud to create a global technology platform to aid its R&D efforts …
dna

Featured Market Report: Gene Therapies Outlook

October 13, 2015 Manufacturing and Production, Research and Development

This report provides a comprehensive view of the clinical, R&D, commercial and competitive landscape of gene therapy, and assesses key …
cinryze_logo

Shire’s Cinryze gets FDA fast track designation

October 13, 2015 Research and Development AMR, FDA, Shire

Shire has announced that the United States Food and Drug Administration (FDA) has granted fast track designation for the investigation …
medimmune_2

AstraZeneca’s MedImmune joins Human Vaccines Project

October 13, 2015 Research and Development Human Vaccines Project, MedImmune

MedImmune has joined the Human Vaccines Project, which aims to accelerate the research and development of vaccines and immunotherapies for …
gamidi_cell_logo

Novartis invests further $15m into Gamida Cell

October 13, 2015 Research and Development, Sales and Marketing Gamida Cell, Novartis, pharma mergers and acquisitions

Novartis is to invest an extra $15 million into Israeli stem cell therapy developer Gamida Cell, adding an additional 2.5% …
s_oschmann_2015

Stefan Oschmann promoted to top job at Merck KGaA

October 13, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA, Stefan Oschmann

Merck KGaA has announced the promotion of its deputy chief executive, Stefan Oschmann, to the role of chief executive, starting …
oma_nice

NICE launches new service to speed NHS adoption of health technologies

October 13, 2015 Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, OMA, market access, office for market access

NICE is introducing a new service, the Office for Market Access (OMA), to work with industry to speed up NHS …
berg_niven_narain

Berg interview: artificial intelligence and big data join the war on disease

October 13, 2015 Medical Communications, Research and Development AI, Berg, Big Data, genomics

Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …
abpi_logo

Health professionals back transparency of their dealings with pharma

October 12, 2015 Research and Development, Sales and Marketing ABPI, transparency

The majority of doctors, nurses, hospital specialists and pharmacists believe that payments received by healthcare professionals (HCPs) from pharmaceutical companies …
think_big_on_genomics_research

Time for pharma to think big on genomics research

October 12, 2015 Research and Development Sir John Chisholm, genomics

Sir John Chisholm, executive chair of Genomics England, is very clear about what the project he is overseeing is – …
biogen_logo

Biogen reports on Tecfidera multiple sclerosis clinical trials

October 9, 2015 Research and Development

Biogen has presented data demonstrating the efficacy and safety of Tecfidera (dimethyl fumarate) across a broad range of people with …
sativex

Almirall presents new data on cannabinoid-based MS treatment

October 9, 2015 Research and Development Almirall, multiple sclerosis

Almirall has presented new clinical evidences of Sativex, the only medicine derived from cannabinoids to treat spasticity symptoms in MS, …
money_pills

Oncology groups and doctors fight for lower-priced cancer treatments

October 9, 2015 Medical Communications, Research and Development, Sales and Marketing

Oncology groups such as the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) are working …
merckincweb2

Merck announces positive Elbasvir/Grazoprevir trial results

October 9, 2015 Research and Development

Merck has announced the publication of results from C-SURFER, the first Phase III clinical trial to investigate an all-oral, ribavirin-free …
The Gateway to Local Adoption Series

Latest content